(Q45354609)

English

Gene transfer therapy by either type 1 or type 2 adeno-associated virus expressing human prostaglandin I2 synthase gene is effective for treatment of pulmonary arterial hypertension

scientific article published on 24 September 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Gene transfer therapy by either type 1 or type 2 adeno-associated virus expressing human prostaglandin I2 synthase gene is effective for treatment of pulmonary arterial hypertension (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

author name string

Masaharu Kataoka

1

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Takashi Kawakami

2

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Yuichi Tamura

3

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Hideaki Yoshino

4

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Toru Satoh

5

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Tadashi Tanabe

6

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Keiichi Fukuda

7

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

publication date

24 September 2012

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Journal of Cardiovascular Pharmacology and Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

54-59

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Primary pulmonary hypertension. A national prospective study

1 reference

https://api.crossref.org/works/10.1177%2F1074248412457046

21 January 2018

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

1 reference

https://api.crossref.org/works/10.1177%2F1074248412457046

21 January 2018

Primary pulmonary hypertension: a vascular biology and translational research "Work in progress".

1 reference

https://api.crossref.org/works/10.1177%2F1074248412457046

21 January 2018

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

1 reference

https://api.crossref.org/works/10.1177%2F1074248412457046

21 January 2018

Arachidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel Walls

1 reference

https://api.crossref.org/works/10.1177%2F1074248412457046

21 January 2018

Gene transfer of human prostacyclin synthase ameliorates monocrotaline-induced pulmonary hypertension in rats.

1 reference

https://api.crossref.org/works/10.1177%2F1074248412457046

21 January 2018

The effects of chronic prostacyclin therapy on cardiac output and symptoms in primary pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1177%2F1074248412457046

21 January 2018

Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin)

1 reference

https://api.crossref.org/works/10.1177%2F1074248412457046

21 January 2018

Prostacyclin (epoprostenol) and heart-lung transplantation as treatments for severe pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1177%2F1074248412457046

21 January 2018

Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin

1 reference

https://api.crossref.org/works/10.1177%2F1074248412457046

21 January 2018

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1177%2F1074248412457046

21 January 2018

Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1177%2F1074248412457046

21 January 2018

Survival in primary pulmonary hypertension: the impact of epoprostenol therapy.

1 reference

https://api.crossref.org/works/10.1177%2F1074248412457046

21 January 2018

Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival.

1 reference

https://api.crossref.org/works/10.1177%2F1074248412457046

21 January 2018

Effect of orally active prostacyclin analogue on survival of outpatients with primary pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1177%2F1074248412457046

21 January 2018

Inhaled iloprost for severe pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1177%2F1074248412457046

21 January 2018

Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1177%2F1074248412457046

21 January 2018

AAV-PGIS gene transfer improves hypoxia-induced pulmonary hypertension in mice

1 reference

https://api.crossref.org/works/10.1177%2F1074248412457046

21 January 2018

Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response

1 reference

https://api.crossref.org/works/10.1177%2F1074248412457046

21 January 2018

A long-acting prostacyclin agonist with thromboxane inhibitory activity for pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1177%2F1074248412457046

21 January 2018

Identifiers

10.1177/1074248412457046

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45354609&oldid=2075561997"